BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36862273)

  • 1. Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.
    Katsuya H
    Int J Hematol; 2023 Apr; 117(4):512-522. PubMed ID: 36862273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective.
    Makiyama J; Ishitsuka K; Munakata W; Maruyama D; Nagai H
    Jpn J Clin Oncol; 2023 Dec; 53(12):1104-1111. PubMed ID: 37592900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of adult T-cell leukemia/lymphoma.
    Ishitsuka K
    Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
    Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
    Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.
    Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A
    Front Microbiol; 2020; 11():1207. PubMed ID: 32636814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
    Katsuya H; Ishitsuka K
    J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult T-cell leukemia-lymphoma.
    Tsukasaki K
    Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options for adult T-cell leukemia/lymphoma.
    Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
    Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of future treatment for ATL].
    Ishitsuka K
    Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and treatment of HTLV-1 associated T-cell lymphomas.
    Tsukasaki K; Tobinai K
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
    Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
    Moriki A; Ito S; Horikita F; Tsutsumi Y
    Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.
    Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S
    Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult T-Cell Leukemia-Lymphoma.
    Munakata W; Tobinai K
    Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult T cell leukemia-lymphoma (ATL)].
    Tsukasaki K
    Nihon Rinsho; 2014 Mar; 72(3):531-7. PubMed ID: 24724415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
    Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
    Nasr R; Marçais A; Hermine O; Bazarbachi A
    Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
    Tsukasaki K; Tobinai K
    Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
    Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I
    Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.